Hirayama Hiroto, Suzuki Tadashi
Glycometabolic Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Riken, 2-1 Hirosawa, Wako Saitama, Japan.
Bio Protoc. 2025 Jan 5;15(1):e5151. doi: 10.21769/BioProtoc.5151.
Cytosolic peptide:-glycanase (PNGase/NGLY1 in mammals), an amidase classified under EC:3.5.1.52, is a highly conserved enzyme across eukaryotes that catalyzes the removal of -glycans from glycoproteins, converting -glycosylated asparagine residues into aspartic acid. This enzyme also plays a role in the quality control system for nascent glycoproteins. Despite the development of non-radioisotope-based assay systems such as those using -alkylated RNase or fluorescent-labeled glycopeptides as substrates, these methods are incompatible with crude enzyme sources, primarily due to the degradation of reaction products by contaminating endogenous proteases. We previously developed an assay system using a 5-carboxyfluorescein-labeled glycosylated cyclo-heptapeptide (5FAM-GCP), a substrate remarkably resistant to endogenous peptidase activity. This system enables the accurate measurement of endogenous NGLY1 activity in various samples, including cell lines, tissues, peripheral blood mononuclear cells, and NGLY1-deficient patient-derived cells, without the interference of proteolytic degradation. We recently advanced this approach by producing a novel fluorescence resonance energy transfer (FRET)-based GCP probe (fGCP) and demonstrated its ability to detect endogenous NGLY1 activity across diverse enzyme sources via fluorescence on multiarray plates. This innovative and straightforward assay now offers reliable disease diagnostics and also allows the measurement of endogenous PNGase/NGLY1 activities across various organisms. Key features • fGCP assay enables measurement of endogenous PNGase/NGLY1 activity in cells and tissues. • An aliquot of 1-5 × 10 cells or 50-100 μg of protein extract from tissues is used for this assay. • This assay enables microplate-based real-time measurement of endogenous PNGase/NGLY1 activities. • This protocol requires a fluorescence plate reader equipped with an incubation function.
胞质肽聚糖酶(哺乳动物中的PNGase/NGLY1),一种归类于EC:3.5.1.52的酰胺酶,是一种在真核生物中高度保守的酶,它催化从糖蛋白中去除聚糖,将N - 糖基化天冬酰胺残基转化为天冬氨酸。该酶在新生糖蛋白的质量控制系统中也发挥作用。尽管已经开发了基于非放射性同位素的检测系统,如使用N - 烷基化核糖核酸酶或荧光标记糖肽作为底物的系统,但这些方法与粗酶来源不兼容,主要是因为内源性蛋白酶会降解反应产物。我们之前开发了一种使用5 - 羧基荧光素标记的糖基化环七肽(5FAM - GCP)的检测系统,该底物对内源性肽酶活性具有显著抗性。该系统能够准确测量各种样品中的内源性NGLY1活性,包括细胞系、组织、外周血单核细胞和NGLY1缺陷患者来源的细胞,而不受蛋白水解降解的干扰。我们最近通过生产一种新型的基于荧光共振能量转移(FRET)的GCP探针(fGCP)改进了这种方法,并证明了它能够通过多阵列板上的荧光检测不同酶来源中的内源性NGLY1活性。这种创新且直接的检测方法现在提供了可靠的疾病诊断,还能测量各种生物体中的内源性PNGase/NGLY1活性。关键特性 • fGCP检测能够测量细胞和组织中的内源性PNGase/NGLY1活性。 • 该检测使用1 - 5×10个细胞的等分试样或来自组织的50 - 100μg蛋白质提取物。 • 该检测能够基于微孔板实时测量内源性PNGase/NGLY1活性。 • 本方案需要配备孵育功能的荧光酶标仪。